Cipla Ltd.

In a move aimed at realignment of family shareholding, Cipla patriarch Y K Hamied, Non-Executive Chairman of the company has acquired 5.22% additional stake in the company from his wife Farida Hamied. Following the acquisition, his total holding in the drug firm increased to 20.76% from earlier stake of 15.54%.

The transfer of shares is being done by way of gift. The development comes at a time when the Mumbai-based drug maker is in the midst of a transition in leadership.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.